HALOZYME THERAPEUTICS, INCHALOZYME THERAPEUTICS, INCHALOZYME THERAPEUTICS, INC

HALOZYME THERAPEUTICS, INC

No trades
See on Supercharts

HALO fundamentals

HALOZYME THERAPEUTICS, INC earnings per share and revenue

HALO earnings per share for the last quarter are 25.02 MXN whereas the estimation was 18.88 MXN which accounts for 32.57% surprise. Company revenue for the same period amounts to 5.72 B MXN despite the estimated figure of 4.97 B MXN. Estimated earnings per share for the next quarter are 23.96 MXN, and revenue is expected to reach 6.00 B MXN. Also watch annual changes over time to get a bigger picture of HALO earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise